| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |